Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites;
Labelled Astemizole. Nonsedating-type histamine H1-receptor antagonist. Potential for combination therapy with antivancer drugs such as doxorubicin in resistant leukemia. Antihistaminic.